{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:20:09Z","timestamp":1783556409092,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31572563"],"award-info":[{"award-number":["31572563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47241-y","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T17:33:21Z","timestamp":1778348001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AKR1B1 promotes canine mammary tumorigenesis via activation of PI3K\/AKT signaling and acts as a serum biomarker"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhe","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"47241_CR1","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.3390\/ani13193147","volume":"13","author":"E Vazquez","year":"2023","unstructured":"Vazquez, E. et al. Canine mammary cancer: state of the art and future perspectives. Animals 13, 3147 (2023).","journal-title":"Animals"},{"key":"47241_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2460\/javma.255.7.817","volume":"255","author":"J Litterine-Kaufman","year":"2019","unstructured":"Litterine-Kaufman, J., Casale, S. A. & Mouser, P. J. Prevalence of malignancy in masses from the mammary gland region of dogs with single or multiple masses. J. Am. Vet. Med. Assoc. 255, 817\u2013820 (2019).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"47241_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10911-022-09527-5","volume":"27","author":"IF Perossi","year":"2022","unstructured":"Perossi, I. F. et al. Protein expression of PI3K\/AKT\/mTOR pathway targets validated by gene expression and its correlation with prognosis in canine mammary cancer. J. Mammary Gland Biol. Neoplasia. 27, 241\u2013252 (2022).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"47241_CR4","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3390\/ani13172757","volume":"13","author":"GH Tamarindo","year":"2023","unstructured":"Tamarindo, G. H., Novais, A. A., Chuffa, L. G. A. & Zuccari, D. A. P. C. Metabolic alterations in canine mammary tumors. Animals 13, 2757 (2023).","journal-title":"Animals"},{"key":"47241_CR5","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/ani14131890","volume":"14","author":"DAP de Campos Zuccari","year":"2024","unstructured":"de Campos Zuccari, D. A. P., Novais, A. A. Tamarindo, G. H., & de Almeida Chuffa, L. G. Toward an improved understanding and treatment of canine mammary tumors: insights and advances from the research. Animals 14, 1890 (2024).","journal-title":"Animals"},{"key":"47241_CR6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/ani11072079","volume":"11","author":"SH Kim","year":"2021","unstructured":"Kim, S. H. et al. Dysregulation of PI3K\/Akt\/PTEN pathway in canine mammary tumor. Animals 11, 2079 (2021).","journal-title":"Animals"},{"key":"47241_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12917-023-03782-2","volume":"19","author":"MJ Yoo","year":"2023","unstructured":"Yoo, M. J., Choi, J., Jang, Y., Park, S. Y. & Seol, J. W. Anti-cancer effect of palmatine through inhibition of the PI3K\/AKT pathway in canine mammary gland tumor CMT-U27 cells. BMC Vet. Res. 19, 223 (2023).","journal-title":"BMC Vet. Res."},{"key":"47241_CR8","doi-asserted-by":"publisher","first-page":"25587","DOI":"10.1038\/s41598-024-76820-0","volume":"14","author":"BJ Seung","year":"2024","unstructured":"Seung, B. J. & Sur, J. H. Detection of PIK3CA hotspot mutations in canine mammary tumors using droplet digital PCR: tissue validation and liquid biopsy feasibility. Sci. Rep. 14, 25587 (2024).","journal-title":"Sci. Rep."},{"key":"47241_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.32604\/or.2024.049918","volume":"32","author":"S Nagini","year":"2024","unstructured":"Nagini, S., Kallamadi, P. R., Tanagala, K. K. K. & Reddy, G. B. Aldo-keto reductases: role in cancer development and theranostics. Oncol. Res. 32, 1287 (2024).","journal-title":"Oncol. Res."},{"key":"47241_CR10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3390\/biology14101422","volume":"14","author":"G Sardelli","year":"2025","unstructured":"Sardelli, G., Felice, F., Mosca, R., Avanatti, M. & Moschini, R. Aldose reductase involvement in EMT: emerging insights and current proposed molecular mechanisms. Biology 14, 1422 (2025).","journal-title":"Biology"},{"key":"47241_CR11","doi-asserted-by":"publisher","first-page":"8890","DOI":"10.1111\/jcmm.15581","volume":"24","author":"R Khayami","year":"2020","unstructured":"Khayami, R., Hashemi, S. R. & Kerachian, M. A. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential. J. Cell. Mol. Med. 24, 8890\u20138902 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"47241_CR12","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.18632\/aging.205041","volume":"15","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway. Aging (Albany NY). 15, 9661 (2023).","journal-title":"Aging (Albany NY)"},{"key":"47241_CR13","doi-asserted-by":"publisher","first-page":"e16709","DOI":"10.7717\/peerj.16709","volume":"12","author":"L Li","year":"2024","unstructured":"Li, L. et al. Proteomics-based screening of AKR1B1 as a therapeutic target and validation study for sepsis-associated acute kidney injury. PeerJ 12, e16709 (2024).","journal-title":"PeerJ"},{"key":"47241_CR14","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41418-024-01393-4","volume":"31","author":"Q Zhao","year":"2024","unstructured":"Zhao, Q. et al. AKR1B1-dependent fructose metabolism enhances malignancy of cancer cells. Cell. Death Differ. 31, 1611\u20131624 (2024).","journal-title":"Cell. Death Differ."},{"key":"47241_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/nsr\/nwy076","volume":"6","author":"GD Wang","year":"2019","unstructured":"Wang, G. D. et al. Structural variation during dog domestication: insights from gray wolf and dhole genomes. Natl. Sci. Rev. 6, 110\u2013122 (2019).","journal-title":"Natl. Sci. Rev."},{"key":"47241_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.hlife.2023.12.002","volume":"2","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Aldo-keto reductase 1B: much learned, much more to do. hLife 2, 154\u2013178 (2024).","journal-title":"hLife"},{"key":"47241_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0300985810393258","volume":"48","author":"M Goldschmidt","year":"2011","unstructured":"Goldschmidt, M., Pe\u00f1a, L., Rasotto, R. & Zappulli, V. Classification and grading of canine mammary tumors. Vet. Pathol. 48, 117\u2013131 (2011).","journal-title":"Vet. Pathol."},{"key":"47241_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1476-5829.2011.00269.x","volume":"10","author":"K Pawlowski","year":"2012","unstructured":"Pawlowski, K. et al. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line. Vet. Comp. Oncol. 10, 2\u201315 (2012).","journal-title":"Vet. Comp. Oncol."},{"key":"47241_CR19","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1038\/s41598-021-85029-4","volume":"11","author":"Y Fan","year":"2021","unstructured":"Fan, Y. et al. Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients. Sci. Rep. 11, 6651 (2021).","journal-title":"Sci. Rep."},{"key":"47241_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.33393\/jcb.2025.3564","volume":"14","author":"D Singh","year":"2025","unstructured":"Singh, D. et al. Diagnostic value of carcinoembryonic antigen, cancer antigen 15-3, and cell-free DNA as blood biomarkers in early detection of canine mammary tumor. J. Circulating Biomarkers. 14, 30 (2025).","journal-title":"J. Circulating Biomarkers"},{"key":"47241_CR21","doi-asserted-by":"publisher","first-page":"117579","DOI":"10.1016\/j.theriogenology.2025.117579","volume":"247","author":"H \u00c7olako\u011flu","year":"2025","unstructured":"\u00c7olako\u011flu, H. et al. Evaluation of serum CA15-3, CEA, Ki-67, PDL-1 and VEGF as a potential diagnostic and prognostic biomarkers in canine mammary tumors. Theriogenology, 247, 117579 (2025).","journal-title":"Theriogenology"},{"key":"47241_CR22","first-page":"8195","volume":"15","author":"SM Abdelmegeed","year":"2018","unstructured":"Abdelmegeed, S. M. & Mohammed, S. Canine mammary tumors as a model for human disease. Oncol. Lett. 15, 8195\u20138205 (2018).","journal-title":"Oncol. Lett."},{"key":"47241_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4048\/jbc.2023.26.e4","volume":"26","author":"JY Kwon","year":"2023","unstructured":"Kwon, J. Y., Moskwa, N., Kang, W., Fan, T. M. & Lee, C. Canine as a comparative and translational model for human mammary tumor. J. breast cancer. 26, 1 (2023).","journal-title":"J. Breast Cancer"},{"key":"47241_CR24","doi-asserted-by":"publisher","first-page":"9319651","DOI":"10.1155\/2024\/9319651","volume":"2024","author":"A Razavirad","year":"2024","unstructured":"Razavirad, A., Rismanchi, S., Mortazavi, P. & Muhammadnejad, A. Canine mammary tumors as a potential model for human breast cancer in comparative oncology. Vet. Med. Int. 2024, 9319651. (2024).","journal-title":"Vet. Med. Int."},{"key":"47241_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1084\/jem.20160903","volume":"214","author":"X Wu","year":"2017","unstructured":"Wu, X. et al. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. J. Exp. Med. 214, 1065\u20131079 (2017).","journal-title":"J. Exp. Med."},{"key":"47241_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2018.00160","volume":"8","author":"N Koundouros","year":"2018","unstructured":"Koundouros, N. & Poulogiannis, G. Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer. Front. Oncol. 8, 160 (2018).","journal-title":"Front. Oncol."},{"key":"47241_CR27","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3390\/antiox11122347","volume":"11","author":"T Tanawattanasuntorn","year":"2022","unstructured":"Tanawattanasuntorn, T., Rattanaburee, T., Thongpanchang, T. & Graidist, P. Trans-(\u00b1)-kusunokinin binding to AKR1B1 inhibits oxidative stress and proteins involved in migration in aggressive breast cancer. Antioxidants 11, 2347 (2022).","journal-title":"Antioxidants"},{"key":"47241_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He, Y. et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal. Transduct. Target. therapy. 6, 425 (2021).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"47241_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB signaling: navigating the network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"47241_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/ani11020365","volume":"11","author":"P Asproni","year":"2021","unstructured":"Asproni, P. et al. An immunohistochemical study of the PTEN\/AKT pathway involvement in canine and feline mammary tumors. Animals 11, 365 (2021).","journal-title":"Animals"},{"key":"47241_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/03009858231207021","volume":"61","author":"TK Meuten","year":"2024","unstructured":"Meuten, T. K., Dean, G. A. & Thamm, D. H. The PI3K-AKT-mTOR signal transduction pathway in canine cancer. Vet. Pathol. 61, 339\u2013356 (2024).","journal-title":"Vet. Pathol."},{"key":"47241_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/ijms26010145","volume":"26","author":"C Mei","year":"2024","unstructured":"Mei, C. et al. Dysregulated signaling pathways in canine mammary tumor and human triple negative breast cancer: Advances and potential therapeutic targets. Int. J. Mol. Sci. 26, 145 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"47241_CR33","first-page":"290","volume":"46","author":"BQ Pinheiro","year":"2022","unstructured":"Pinheiro, B. Q., da Silva, I., Faustino, A. & da Silva, L. D. M. The prognostic value of serum neoplastic biomarkers CA15-3 and CEA in canine mammary neoplasms: a review. Rev. Bras. Reprod. Anim. 46, 290\u2013297 (2022).","journal-title":"Rev. Bras. Reprod. Anim."},{"key":"47241_CR34","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.jhepr.2023.100974","volume":"6","author":"N Syamprasad","year":"2024","unstructured":"Syamprasad, N. et al. AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma. JHEP Rep. 6, 100974 (2024).","journal-title":"JHEP Rep."},{"key":"47241_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41392-025-02321-9","volume":"10","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma. Signal. Transduct. Target. Therapy. 10, 244 (2025).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"47241_CR36","doi-asserted-by":"publisher","first-page":"1271097","DOI":"10.3389\/fvets.2023.1271097","volume":"10","author":"PT Carvalho","year":"2023","unstructured":"Carvalho, P. T. et al. Comparative epidemiological study of breast cancer in humans and canine mammary tumors: insights from Portugal. Front. Veterinary Sci. 10, 1271097 (2023).","journal-title":"Front. Veterinary Sci."},{"key":"47241_CR37","doi-asserted-by":"publisher","first-page":"18051","DOI":"10.1038\/s41598-022-21706-2","volume":"12","author":"M Inglebert","year":"2022","unstructured":"Inglebert, M. et al. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer. Sci. Rep. 12, 18051 (2022).","journal-title":"Sci. Rep."},{"key":"47241_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12917-024-04085-w","volume":"20","author":"SY Park","year":"2024","unstructured":"Park, S. Y. et al. Establishment of canine mammary gland tumor cell lines harboring PI3K\/Akt activation as a therapeutic target. BMC Vet. Res. 20, 233 (2024).","journal-title":"BMC Vet. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47241-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:12:04Z","timestamp":1783555924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47241-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47241"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47241-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21344"}}